197 related articles for article (PubMed ID: 33332878)
41. Cardioselective beta-blockers for reversible airway disease.
Salpeter S; Ormiston T; Salpeter E
Cochrane Database Syst Rev; 2002; (4):CD002992. PubMed ID: 12519582
[TBL] [Abstract][Full Text] [Related]
42. Beta Blockers and Chronic Obstructive Pulmonary Disease (COPD): Sum of Evidence.
Baou K; Katsi V; Makris T; Tousoulis D
Curr Hypertens Rev; 2021; 17(3):196-206. PubMed ID: 33302840
[TBL] [Abstract][Full Text] [Related]
43. Major comorbidities lead to the risk of adverse cardiovascular events in chronic obstructive pulmonary disease patients using inhaled long-acting bronchodilators: a case-control study.
Chen YF; Cheng YC; Chou CH; Chen CY; Yu CJ
BMC Pulm Med; 2019 Dec; 19(1):233. PubMed ID: 31795986
[TBL] [Abstract][Full Text] [Related]
44. Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease.
Rutten FH; Zuithoff NP; Hak E; Grobbee DE; Hoes AW
Arch Intern Med; 2010 May; 170(10):880-7. PubMed ID: 20498416
[TBL] [Abstract][Full Text] [Related]
45. β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol.
Bhatt SP; Connett JE; Voelker H; Lindberg SM; Westfall E; Wells JM; Lazarus SC; Criner GJ; Dransfield MT
BMJ Open; 2016 Jun; 6(6):e012292. PubMed ID: 27267111
[TBL] [Abstract][Full Text] [Related]
46. Effect of β-blockers on the risk of COPD exacerbations according to indication of use: the Rotterdam Study.
Karimi L; Lahousse L; De Nocker P; Stricker BH; Brusselle GG; Verhamme KMC
ERJ Open Res; 2021 Apr; 7(2):. PubMed ID: 34195251
[TBL] [Abstract][Full Text] [Related]
47. Cardioselective Versus Nonselective β-Blockers After Myocardial Infarction in Adults With Chronic Obstructive Pulmonary Disease.
Chung CM; Lin MS; Chang ST; Wang PC; Yang TY; Lin YS
Mayo Clin Proc; 2022 Mar; 97(3):531-546. PubMed ID: 35135688
[TBL] [Abstract][Full Text] [Related]
48. β-Blockers in COPD: A Cohort Study From the TONADO Research Program.
Maltais F; Buhl R; Koch A; Amatto VC; Reid J; Grönke L; Bothner U; Voß F; McGarvey L; Ferguson GT
Chest; 2018 Jun; 153(6):1315-1325. PubMed ID: 29355547
[TBL] [Abstract][Full Text] [Related]
49. β-Blockers, heart disease and COPD: current controversies and uncertainties.
Baker JG; Wilcox RG
Thorax; 2017 Mar; 72(3):271-276. PubMed ID: 27927840
[TBL] [Abstract][Full Text] [Related]
50. Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD).
Duffy S; Marron R; Voelker H; Albert R; Connett J; Bailey W; Casaburi R; Cooper JA; Curtis JL; Dransfield M; Han MK; Make B; Marchetti N; Martinez F; Lazarus S; Niewoehner D; Scanlon PD; Sciurba F; Scharf S; Reed RM; Washko G; Woodruff P; McEvoy C; Aaron S; Sin D; Criner GJ;
Respir Res; 2017 Jun; 18(1):124. PubMed ID: 28629419
[TBL] [Abstract][Full Text] [Related]
51. Improving outcomes in chronic obstructive pulmonary disease by taking beta-blockers after acute myocardial infarction: a nationwide observational study.
Wang WH; Cheng CC; Mar GY; Wei KC; Huang WC; Liu CP
Heart Vessels; 2019 Jul; 34(7):1158-1167. PubMed ID: 30680495
[TBL] [Abstract][Full Text] [Related]
52. Cardio-selective and non-selective beta-blockers in chronic obstructive pulmonary disease: effects on bronchodilator response and exercise.
Chang CL; Mills GD; McLachlan JD; Karalus NC; Hancox RJ
Intern Med J; 2010 Mar; 40(3):193-200. PubMed ID: 19383058
[TBL] [Abstract][Full Text] [Related]
53. Beta-blocker use in patients with chronic obstructive pulmonary disease: A systematic review: A systematic review of βB in COPD.
Ruzieh M; Baugh AD; Al Jebbawi L; Edwards ES; Jia KQ; Dransfield MT; Foy AJ
Trends Cardiovasc Med; 2023 Jan; 33(1):53-61. PubMed ID: 34856338
[TBL] [Abstract][Full Text] [Related]
54. Frequency of β-Blocker Use Following Exacerbations of COPD in Patients with Compelling Indication for Use.
Pinner N; Oliver W; Veasey T; Starr J; Eudaley S; Hutchison A; Wargo K
South Med J; 2019 Nov; 112(11):586-590. PubMed ID: 31682740
[TBL] [Abstract][Full Text] [Related]
55. Beta-blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditions.
Albouaini K; Andron M; Alahmar A; Egred M
Int J Chron Obstruct Pulmon Dis; 2007; 2(4):535-40. PubMed ID: 18268926
[TBL] [Abstract][Full Text] [Related]
56. Detrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockers.
van der Woude HJ; Zaagsma J; Postma DS; Winter TH; van Hulst M; Aalbers R
Chest; 2005 Mar; 127(3):818-24. PubMed ID: 15764762
[TBL] [Abstract][Full Text] [Related]
57. β-Blockers and chronic obstructive pulmonary disease: inappropriate avoidance?
Minor DS; Meyer AM; Long RC; Butler KR
J Clin Hypertens (Greenwich); 2013 Dec; 15(12):925-30. PubMed ID: 24102872
[TBL] [Abstract][Full Text] [Related]
58. Long-term effects of beta-blocker use on lung function in Japanese patients with chronic obstructive pulmonary disease.
Oda N; Miyahara N; Ichikawa H; Tanimoto Y; Kajimoto K; Sakugawa M; Kawai H; Taniguchi A; Morichika D; Tanimoto M; Kanehiro A; Kiura K
Int J Chron Obstruct Pulmon Dis; 2017; 12():1119-1124. PubMed ID: 28435245
[TBL] [Abstract][Full Text] [Related]
59. Management of chronic obstructive pulmonary disease: A review focusing on exacerbations.
Bollmeier SG; Hartmann AP
Am J Health Syst Pharm; 2020 Feb; 77(4):259-268. PubMed ID: 31930287
[TBL] [Abstract][Full Text] [Related]
60. Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular Diseases.
Cazzola M; Calzetta L; Rinaldi B; Page C; Rosano G; Rogliani P; Matera MG
Drugs; 2017 May; 77(7):721-732. PubMed ID: 28349353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
